Devyser Diagnostics AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 37.7 million compared to SEK 30.9 million a year ago. Net loss was SEK 14.6 million compared to SEK 14.3 million a year ago. Basic loss per share from continuing operations was SEK 0.9 compared to SEK 0.9 a year ago. Diluted loss per share from continuing operations was SEK 0.9 compared to SEK 0.9 a year ago.
For the six months, sales was SEK 77.2 million compared to SEK 61.3 million a year ago. Net loss was SEK 34.5 million compared to SEK 20.4 million a year ago. Basic loss per share from continuing operations was SEK 2.14 compared to SEK 1.29 a year ago. Diluted loss per share from continuing operations was SEK 2.14 compared to SEK 1.29 a year ago.